Telomerase Cajal body protein 1 depletion inhibits telomerase trafficking to telomeres and induces G1 cell cycle arrest in A549 cells

Oncology Letters

Volumn 8, Issue 3, 2014, Pages 1009-1016

  Yuan, Ping ^a   Wang, Zhitian ^a   Lv, Wang ^a   Pan, Hui ^a   Yang, Yunhai ^a   Yuan, Xiaoshuai ^a   Hu, Jian ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Antiproliferation; Cell cycle arrest; Telomerase Cajal body protein 1; Telomerase trafficking

Indexed keywords

CELL ENZYME; HOLOENZYME; SMALL INTERFERING RNA; TELOMERASE; TELOMERASE CAJAL BODY PROTEIN 1; TELOMERASE REVERSE TRANSCRIPTASE; UNCLASSIFIED DRUG;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE REGULATION; CELL DENSITY; CELL MIGRATION; CELL PROLIFERATION; COILED BODY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLYSIS; DENSITOMETRY; ENZYME ACTIVITY; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; GENE SILENCING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; LUNG CANCER CELL LINE; MTT ASSAY; PLASMID; PROTEIN DEPLETION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; TELOMERE; TELOMERIC REPEAT AMPLIFICATION PROTOCOL; WESTERN BLOTTING;

EID: 84904259784     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2306     Document Type: Article

References (35)

1. Greider CW and Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 43: 405-413, 1985.
2. Shay JW and Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer 33: 787-791, 1997.
3. Cui W, Wylie D, Aslam S, et al: Telomerase-immortalized sheep fibroblasts can be reprogrammed by nuclear transfer to undergo early development. Biol Reprod 69: 15-21, 2003.
4. Bolzán AD: Chromosomal aberrations involving telomeres and interstitial telomeric sequences. Mutagenesis 27: 1-15, 2012.
5. Granger MP, Wright WE and Shay JW: Telomerase in cancer and aging. Crit Rev Oncol Hematol 41: 29-40, 2002.
6. Hoos A, Hepp HH, Kaul S, Ahlert T, Bastert G and Wallwiener D: Telomerase activity correlates with tumor aggressiveness and reflects therapy effect in breast cancer. Int J Cancer 79: 8-12, 1998.
7. Yashima K, Milchgrub S, Gollahon LS, et al: Telomerase enzyme activity and RNA expression during the multistage pathogenesis of breast carcinoma. Clin Cancer Res 4: 229-234, 1998.
8. Mokbel K and Williams NJ: Telomerase and breast cancer: from diagnosis to therapy. Int J Surg Investig 2: 85-88, 2000.
9. Feng J, Funk WD, Wang SS, et al: The RNA component of human telomerase. Science 269: 1236-1241, 1995.
10. Cech TR, Nakamura TM and Lingner J: Telomerase is a true reverse transcriptase. A review. Biochemistry (Mosc) 62: 1202-1205, 1997.
11. Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S and Greider CW: Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 56: 645-650, 1996.
12. Ito H, Kyo S, Kanaya T, Takakura M, Inoue M and Namiki M: Expression of human telomerase subunits and correlation with telomerase activity in urothelial cancer. Clin Cancer Res 4: 1603-1608, 1998.
13. Kyo S, Kanaya T, Takakura M, Tanaka M and Inoue M: Human telomerase reverse transcriptase as a critical determinant of telomerase activity in normal and malignant endometrial tissues. Int J Cancer 80: 60-63, 1999.
14. Cristofari G, Adolf E, Reichenbach P, et al: Human telomerase RNA accumulation in Cajal bodies facilitates telomerase recruitment to telomeres and telomere elongation. Mol Cell 27: 882-889, 2007.
15. Zhu Y, Tomlinson RL, Lukowiak AA, Terns RM and Terns MP: Telomerase RNA accumulates in Cajal bodies in human cancer cells. Mol Biol Cell 15: 81-90, 2004.
16. Tomlinson RL, Abreu EB, Ziegler T, et al: Telomerase reverse transcriptase is required for the localization of telomerase RNA to cajal bodies and telomeres in human cancer cells. Mol Biol Cell 19: 3793-3800, 2008.
17. Arnoult N, Schluth-Bolard C, Letessier A, et al: Replication timing of human telomeres is chromosome arm-specific, influenced by subtelomeric structures and connected to nuclear localization. PLoS Genet 6: e1000920, 2010.
18. Mahmoudi S, Henriksson S, Weibrecht I, et al: WRAP53 is essential for Cajal body formation and for targeting the survival of motor neuron complex to Cajal bodies. PLoS Biol 8: e1000521, 2010.
19. Tycowski KT, Shu MD, Kukoyi A and Steitz JA: A conserved WD40 protein binds the Cajal body localization signal of scaRNP particles. Mol Cell 34: 47-57, 2009.
20. Venteicher AS, Abreu EB, Meng Z, et al: A human telomerase holoenzyme protein required for Cajal body localization and telomere synthesis. Science 323: 644-648, 2009.
21. Egan ED and Collins K: An enhanced H/ACA RNP assembly mechanism for human telomerase RNA. Mol Cell Biol 32: 2428-2439, 2012.
22. Smogorzewska A, van Steensel B, Bianchi A, et al: Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 20: 1659-1668, 2000.
23. Herbst RS, Heymach JV and Lippman SM: Lung cancer. N Engl J Med 359: 1367-1380, 2008.
24. Helmstetter CE: DNA synthesis during the division cycle of rapidly growing Escherichia coli B/r. J Mol Biol 31: 507-518, 1968.
25. Hu J, Hwang SS, Liesa M, et al: Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer. Cell 148: 651-663, 2012.
26. Henson JD, Neumann AA, Yeager TR and Reddel RR: Alternative lengthening of telomeres in mammalian cells. Oncogene 21: 598-610, 2002.
27. Slatter TL, Tan X, Yuen YC, et al: The alternative lengthening of telomeres pathway may operate in non-neoplastic human cells. J Pathol 226: 509-518, 2012.
28. Lundblad V and Blackburn EH: An alternative pathway for yeast telomere maintenance rescues est1-senescence. Cell 73: 347-360, 1993.
29. Bryan TM, Englezou A, Dalla-Pozza L, Dunham MA and Reddel RR: Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines. Nat Med 3: 1271-1274, 1997.
30. Pajalunga D, Mazzola A, Franchitto A, Puggioni E and Crescenzi M: The logic and regulation of cell cycle exit and reentry. Cell Mol Life Sci 65: 8-15, 2008.
31. Cesare AJ and Karlseder J: A three-state model of telomere control over human proliferative boundaries. Curr Opin Cell Biol 24: 731-738, 2012.
32. Verdun RE and Karlseder J: The DNA damage machinery and homologous recombination pathway act consecutively to protect human telomeres. Cell 127: 709-720, 2006.
33. Stern JL, Zyner KG, Pickett HA, Cohen SB and Bryan TM: Telomerase recruitment requires both TCAB1 and Cajal bodies independently. Mol Cell Biol 32: 2384-2395, 2012.
34. Zhong FL, Batista LF, Freund A, Pech MF, Venteicher AS and Artandi SE: TPP1 OB-fold domain controls telomere maintenance by recruiting telomerase to chromosome ends. Cell 150: 481-494, 2012.
35. Schildkraut JM, Goode EL, Clyde MA, et al; Australian Ovarian Cancer Study Group: Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res 69: 2349-2357, 2009.